S2012: Randomized Phase II/III Trial of First Line Platinum/Etoposide with or without Atezolizumab (NSC#783608) in Patients with Advanced or Metastatic Poorly Differentiated Extrapulmonary Neuroendocrine Carcinomas (NEC)
- Title
- Randomized Phase II/III Trial of First Line Platinum/Etoposide with or without Atezolizumab (NSC#783608) in Patients with Advanced or Metastatic Poorly Differentiated Extrapulmonary Neuroendocrine Carcinomas (NEC)
- Principal Investigator
- Daboul, Nour
- Phase
- II/III
- Age Group
- Adult
- Applicable Disease Sites
- Gastrointestinal Cancers
- Other Cancers
- Participating Institutions
- Mary Babb Randolph Cancer Center
- United Hospital Center
- Contacts
- Sabrina Rexroad, RN
- Research Nurse
- Email: sabrina.rexroad1@wvumedicine.org
- Melissa Boggess, RN
- Research Nurse
- Phone: +1 304-487-7515
- Email: melissa.boggess1@wvumedicine.org
- Nnennaya Opara
- Clinical Research Specialist
- Phone: +1 681-342-1000
- Email: nnennaya.opara1@wvumedicine.org
- Meg Zafiris
- Research Specialist
- Email: margaret.zafiris@hsc.wvu.edu